Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Amendment to Zavesca NDA to be filed

Nov. 25, 2002

Kyorin increases investment in collaborative partner

Nov. 25, 2002

Sumitomo scientists identify new compounds for arthritis and bone diseases

Nov. 22, 2002

Hemolink cleared for evaluation in phase II orthopedic surgery trial

Nov. 22, 2002

E.U. approval for Somavert

Nov. 21, 2002

Beneficial effects reported for recombinant human GAA in infantile Pompe's disease

Nov. 21, 2002

Novel 5-HT2C agonists with utility in obesity and other disorders

Nov. 20, 2002

New series of retinoid RXR modulators claimed by Lilly and Ligand researchers

Nov. 20, 2002

SMP-534, an orally active TGF-beta inhibitor, shows promise for diabetic renal disease

Nov. 19, 2002

New Novartis program to evaluate once-yearly zoledronic acid in osteoporosis

Nov. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...